Zoetis Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Great. So good morning, everybody. On behalf of Morgan Stanley, this is Dave Risinger. I cover both major and specialty pharmaceuticals. And it's very much my pleasure to welcome the 2 leaders of the Zoetis management team this morning.
I do need to refer you to disclaimers at www.morganstanley.com/researchdisclosures. And just note that if you're a member of the press, we ask that you disconnect and reach out to Morgan Stanley Public Relations.
So this morning, I want to welcome Kristin Peck, who is the CEO of Zoetis; and Glenn David, who's Executive Vice President and CFO. And we are going to get right into it.
Questions & Answers
So I guess, to start off, Kristin, so congratulations on the exceptional
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
